HPV CAPSID ASSEMBLY

HPV 衣壳组件

基本信息

项目摘要

Both epidemiologic and molecular biological studies indicate that certai human papillomavirus types, particularly HPV 16 and HPV 18 are involved in the etiology of squamous cell carcinomas of the cervix. Prevention of HPV infection with vaccines, or the use of vaccines or antiviral agents to modulate infection and tumor development is an extremely important goal. The recent development in our laboratory of a recombinant vaccinia virus expression system that allows the assembly of HPV proteins into capsids provides an opportunity to study capsid structure and assembly. This information could be used to design peptides or antibodies that interfere with the formation of infectious virions. The study will examine three HPV types: 1,6 and 16 to allow an assessment of the features that are shared among papillomaviruses and those that are unique to a particular type. The study will combine biochemical, genetic, microscopic and structural approaches to characterize HPV capsids. The specific aims of this proposal are: (1) To characterize the structure of the L1 capsomers and capsid. Molecular modeling will be used to determine if there is structural similarity between the L1 proteins of papillomaviruses and the VP1 proteins of polyomaviruses. Image analysis of cryoelectron micrographs and mass measurements of scanning transmission electron micrographs will be used to study the L1 capsomers and the capsid at the 3.0 nm level and to attempt to locate L2. Attempts will be made to crystallize the L1 capsomer. (2) To characterize the domains of the capsid proteins that are required for self-assembly including the intracapsomer among the fiv L1 - containing subunits, the intercapsomer contacts among the L1 proteins in the capsid shell, and interactions between L1 and L2. The ability of L1 to form intra- and intercapsomer contacts will be assessed using wild type and mutated capsid proteins by coimmunoprecipitation, fractionation analysis, electron microscopy, and the two hybrid system of Fields and Song. The two hybrid system will also be used to identify contacts between L1 and L2. (3) To characterize post-translational modifications of the L1 and L2 proteins. Post-translational modifications will be determined by metabolic labeling. 2D gel analysis and mutagenesis. Modifications will be compared among the three HPV types in vaccinia and baculovirus expression systems to look for consistent changes. The ability of L2 to effect posttranslational modification of L1 will be examined. (4) To characterize the requirements for encapsidation of viral DNA. Viral DNA will be replicated to high copy number transiently by the expression of the E1 and E2 genes, or will exist as high copy episomal DNA in cell lines, and will be packaged using the recombinant vaccinia viruses to provide the capsid proteins. The requirement for the L2 protein will be determined.
流行病学和分子生物学研究都表明,这是肯定的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DENISE A. GALLOWAY其他文献

DENISE A. GALLOWAY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DENISE A. GALLOWAY', 18)}}的其他基金

Human Papillomavirus and Polyomavirus Associated Malignancies.
人乳头瘤病毒和多瘤病毒相关恶性肿瘤。
  • 批准号:
    9762877
  • 财政年份:
    2017
  • 资助金额:
    $ 23.95万
  • 项目类别:
Human Papillomavirus and Polyomavirus Associated Malignancies.
人乳头瘤病毒和多瘤病毒相关恶性肿瘤。
  • 批准号:
    10601410
  • 财政年份:
    2017
  • 资助金额:
    $ 23.95万
  • 项目类别:
Human Papillomavirus and Polyomavirus Associated Malignancies.
人乳头瘤病毒和多瘤病毒相关恶性肿瘤。
  • 批准号:
    10219976
  • 财政年份:
    2017
  • 资助金额:
    $ 23.95万
  • 项目类别:
Human Papillomavirus and Polyomavirus Associated Malignancies.
人乳头瘤病毒和多瘤病毒相关恶性肿瘤。
  • 批准号:
    9389980
  • 财政年份:
    2017
  • 资助金额:
    $ 23.95万
  • 项目类别:
Human Papillomavirus and Polyomavirus Associated Malignancies.
人乳头瘤病毒和多瘤病毒相关恶性肿瘤。
  • 批准号:
    10461103
  • 财政年份:
    2017
  • 资助金额:
    $ 23.95万
  • 项目类别:
Human Papillomavirus and Polyomavirus Associated Malignancies.
人乳头瘤病毒和多瘤病毒相关恶性肿瘤。
  • 批准号:
    10669047
  • 财政年份:
    2017
  • 资助金额:
    $ 23.95万
  • 项目类别:
The Role of ALTO in the MCPyV Lifecycle and Tumorigenicity
ALTO 在 MCPyV 生命周期和致瘤性中的作用
  • 批准号:
    8653347
  • 财政年份:
    2014
  • 资助金额:
    $ 23.95万
  • 项目类别:
The Role of ALTO in the MCPyV Lifecycle and Tumorigenicity
ALTO 在 MCPyV 生命周期和致瘤性中的作用
  • 批准号:
    8797092
  • 财政年份:
    2014
  • 资助金额:
    $ 23.95万
  • 项目类别:
MOLECULAR BIOLOGY
分子生物学
  • 批准号:
    8307530
  • 财政年份:
    2011
  • 资助金额:
    $ 23.95万
  • 项目类别:
MOLECULAR MECHANISMS OF GENUS BETA E6 AND E7 PROTEINS
β E6 和 E7 属蛋白质的分子机制
  • 批准号:
    8307528
  • 财政年份:
    2011
  • 资助金额:
    $ 23.95万
  • 项目类别:

相似国自然基金

猪圆环病毒2型核衣壳(capsid)表面 Loops结构及其展示外源抗原表位的研究
  • 批准号:
    2018JJ2177
  • 批准年份:
    2018
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目

相似海外基金

+TIPs as novel host capsid-binding co-factors in early HIV-1 infection
TIP 作为早期 HIV-1 感染中新型宿主衣壳结合辅助因子
  • 批准号:
    10709142
  • 财政年份:
    2023
  • 资助金额:
    $ 23.95万
  • 项目类别:
Under Pressure: Biophysical Mapping of Herpesvirus Capsid Assembly and Genome Packaging
压力之下:疱疹病毒衣壳组装和基因组包装的生物物理图谱
  • 批准号:
    10685823
  • 财政年份:
    2023
  • 资助金额:
    $ 23.95万
  • 项目类别:
Development of Improved HIV-1 Capsid Inhibitors
改进的 HIV-1 衣壳抑制剂的开发
  • 批准号:
    10700506
  • 财政年份:
    2023
  • 资助金额:
    $ 23.95万
  • 项目类别:
Structure of the SARS-CoV-2 Nucleocapsid: building block to viral capsid
SARS-CoV-2 核衣壳的结构:病毒衣壳的构建模块
  • 批准号:
    10728253
  • 财政年份:
    2023
  • 资助金额:
    $ 23.95万
  • 项目类别:
Mechanism of nuclear pore passage of the HIV-1 capsid
HIV-1衣壳核孔通过机制
  • 批准号:
    10762097
  • 财政年份:
    2023
  • 资助金额:
    $ 23.95万
  • 项目类别:
Affinity Gradient-Based Transport of HIV Capsid Cores through the Nuclear Pore Complex
基于亲和梯度的 HIV 衣壳核心通过核孔复合体的运输
  • 批准号:
    10700524
  • 财政年份:
    2023
  • 资助金额:
    $ 23.95万
  • 项目类别:
Initiation of HIV Capsid Assembly Monitored by Mass Photometry
通过质谱光度法监测 HIV 衣壳组装的启动
  • 批准号:
    10649361
  • 财政年份:
    2023
  • 资助金额:
    $ 23.95万
  • 项目类别:
Dehydroamino acids in HIV-1 capsid and matrix proteins: new potential targets for viral inactivation
HIV-1衣壳和基质蛋白中的脱氢氨基酸:病毒灭活的新潜在靶点
  • 批准号:
    10762067
  • 财政年份:
    2023
  • 资助金额:
    $ 23.95万
  • 项目类别:
Delineating HIV-1 nuclear import mechanisms through capsid interaction with MxB and the nuclear pore complex
通过衣壳与 MxB 和核孔复合体相互作用描述 HIV-1 核输入机制
  • 批准号:
    10548633
  • 财政年份:
    2022
  • 资助金额:
    $ 23.95万
  • 项目类别:
Aptamer tools for dissecting HIV-1 capsid function and identifying accessible, biologically relevant interaction surfaces.
用于剖析 HIV-1 衣壳功能并识别可访问的、生物学相关的相互作用表面的适体工具。
  • 批准号:
    10655852
  • 财政年份:
    2022
  • 资助金额:
    $ 23.95万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了